TECH
TECH assists prospective Biotech Companies and Specialist Technology Companies in understanding the applicable Listing Rules and preparing for their listings in Hong Kong before they submit formal listing applications. Key measures include:
- Dedicating a specialised team with experience in reviewing and providing guidance on new listing applications under Chapters 18A and 18C of the Listing Rules.
- Engaging with these companies to understand their businesses and assist them in comprehending the Listing Rules requirements.
- Providing guidance on the eligibility and suitability requirements for listing, including Core Products, Sophisticated Investors, and acceptable sectors for Specialist Technology Industries.
- Offering preliminary guidance on case-specific issues under the Listing Rules.
The Exchange encourages prospective Biotech Companies and Specialist Technology Companies to utilise TECH and initiate communication with the Listing Division by using the enquiry form and email address below:
Enquiry Form: Potential applicant / professional adviser should submit the Technology Enterprises Channel (TECH) - Enquiry Form and the additional information using Form M119.
Email address: IPO_TECH@hkex.com.hk
Confidential filing
Specialist Technology Companies and Biotech Companies, often in early development stages, face significant risks from premature disclosure on their operational strategies, proprietary technologies, and listing plans. To mitigate these risks, the Exchange allows confidential submission of Application Proofs for listings under Chapters 18A and 18C of the Listing Rules. This option is available for listing applications filed after 6 May 2025.
Biotech Companies and Specialist Technology Companies with a WVR structure
Biotech Companies and Specialist Technology Companies that fully meet the requirements under Chapters 18A and 18C of the Listing Rules, respectively, will be presumed to have satisfied the innovative company requirements and the external validation requirement set out in paragraphs 4 and 6 of Chapter 2.2 of the Guide, and will qualify as innovative companies for the purposes of Chapter 8A of the Listing Rules. However, these companies will remain subject to all other applicable requirements under Chapter 8A of the Listing Rules and Chapter 2.2 of the Guide.
These initiatives demonstrate the regulators' commitment in strengthening Hong Kong's position as a premier listing platform for emerging and innovative companies. Should you wish to obtain further information or to discuss what this development might mean for you, please contact our lawyers set out under Contact Information or your usual Baker McKenzie contact.
